Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...
Under the collaboration, Phlow will produce the U.S.-based API, while Fresenius Kabi will manufacture the finished doses for ...
Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
The medication had a market value of roughly $67.6 million for the 12-month period ending October 2025, per IQVIA. Elite Pharmaceuticals and Glenmark, the company's marketing alliance partner, are set ...
Needle-free epinephrine could help overcome patient and caregiver hesitancy in emergencies, supporting the life-saving ...
Asia-Pacific is emerging as the fastest-growing region. The global prefilled auto-injectors market is projected to grow at a CAGR of 8.4% from 2026 to 2033, rising from $5.6b in 2024 to $11.2b by 2033 ...
Amsino International, Inc. is a global medical device manufacturer and supplier focused on delivering high-quality, reliable products to healthcare providers. With a strong emphasis on innovation, ...
Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to onshore the manufacture of Epinephrine Injection, USP, an essential medicine long at risk of chronic shortage in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results